Prudential Financial
SPRY icon

Prudential Financial’s ARS Pharmaceuticals SPRY Stock Holding History

Prudential Financial’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$80.5K Buy
+10,045
New +$86.4K ﹤0.01% 2369
2025
Q4 		– Sell
-27,600
Closed -$277K – 2431
2025
Q3 		$277K Buy
+27,600
New +$396K ﹤0.01% 2119

Other funds holding SPRY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $446M AUM 84.15% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prudential Financial's SPRY Position: Q2 2026 in Review

Prudential Financial opened a new position in ARS Pharmaceuticals (SPRY) in Q2 2026: 10,045 shares worth $80.5K. The stake represents ﹤0.01% of the portfolio and ranks #2369 among its holdings. This is a return to the name: Prudential Financial previously reported a position in SPRY as recently as Q3 2025.

Prudential Financial first reported a position in SPRY in Q3 2025 and has held it in 2 quarters since. The position peaked at $277K in Q3 2025. 139 funds tracked by Wall St. Rank hold SPRY as of Q2 2026.

  • Prudential Financial held 10,045 shares of ARS Pharmaceuticals worth $80.5K as of Q2 2026.
  • ARS Pharmaceuticals was a new Prudential Financial position in Q2 2026.
  • ARS Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2369 holding.
  • Prudential Financial first reported a position in ARS Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Prudential Financial's ARS Pharmaceuticals position peaked at $277K in Q3 2025.
  • 139 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.